Neurocognitive Analysis of Low-level Arsenic Exposure and Executive Function Mediated by Brain Anomalies Among Children, Adolescents, and Young Adults in India

  • Nilakshi Vaidya
    Centre for Population Neuroscience and Precision Medicine, Department of Psychiatry and Neuroscience, Charité Universitätsmedizin Berlin, Berlin, Germany
  • Bharath Holla
    Department of Psychiatry and Integrative Medicine, National Institute of Mental Health and Neurosciences, Bangalore, India
  • Jon Heron
    Centre for Public Health, Bristol Medical School, University of Bristol, Bristol, United Kingdom
  • Eesha Sharma
    Department of Child & Adolescent Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India
  • Yuning Zhang
    Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, United Kingdom
  • Gwen Fernandes
    Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
  • Udita Iyengar
    Institute of Psychology, Psychiatry & Neuroscience, King’s College London, London, United Kingdom
  • Alex Spiers
    MRC (Medical Research Council) Centre for Environment and Health, Imperial College London, London, United Kingdom
  • Anupa Yadav
    Indian Council of Medical Research–Centre for Ageing and Mental Health, Kolkata, India
  • Surajit Das
    Indian Council of Medical Research–Centre for Ageing and Mental Health, Kolkata, India
  • Sanjit Roy
    Indian Council of Medical Research–Centre for Ageing and Mental Health, Kolkata, India
  • Chirag K. Ahuja
    Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Gareth J. Barker
    Department of Neuroimaging, Institute of Psychology, Psychiatry & Neuroscience, King’s College London, London, United Kingdom
  • Debasish Basu
    Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Rose Dawn Bharath
    Department of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neurosciences, Bangalore, India
  • Matthew Hickman
    Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
  • Sanjeev Jain
    Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India
  • Kartik Kalyanram
    Rishi Valley, Rural Health Centre, India
  • Kamakshi Kartik
    Rishi Valley, Rural Health Centre, India
  • Murali Krishna
    Foundation for Research and Advocacy in Mental Health, Mysore, India
  • Ghattu Krishnaveni
    Epidemiology Research Unit, CSI Holdsworth Memorial Hospital, Mysore, India
  • Kalyanaraman Kumaran
    Epidemiology Research Unit, CSI Holdsworth Memorial Hospital, Mysore, India
  • Rebecca Kuriyan
    Division of Nutrition, St John’s Research Institute, Bangalore, India
  • Pratima Murthy
    Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India
  • Dimitri Papadopoulos Orfanos
    NeuroSpin, Commissariat à l’Énergie Atomique et aux Énergies Alternatives, Université Paris-Saclay, Paris, France
  • Meera Purushottam
    Molecular Genetics Laboratory, National Institute of Mental Health and Neurosciences, Bangalore, India
  • Sunita Simon Kurpad
    Department of Psychiatry, St John’s Medical College and Hospital, Bangalore, India
  • Lenin Singh
    Regional Institute of Medical Sciences, Imphal, Manipur, India
  • Roshan Singh
    Regional Institute of Medical Sciences, Imphal, Manipur, India
  • B. N. Subodh
    Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Mireille Toledano
    MRC (Medical Research Council) Centre for Environment and Health, Imperial College London, London, United Kingdom
  • Henrik Walter
    Psychiatry, Psychiatric Neuroscience and Neurophilosophy, Research Division of Mind and Brain, Charité-Universitätsmedizin Berlin, Berlin, Germany
  • Sylvane Desrivières
    Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, United Kingdom
  • Amit Chakrabarti
    Indian Council of Medical Research–Centre for Ageing and Mental Health, Kolkata, India
  • Vivek Benegal
    Centre for Addiction Medicine, National Institute of Mental Health and Neurosciences, Bangalore, India
  • Gunter Schumann
    Centre for Population Neuroscience and Precision Medicine, Department of Psychiatry and Neuroscience, Charité Universitätsmedizin Berlin, Berlin, Germany
  • Mathew Varghese
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Kandavel Thennarasu
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Urvakhsh Metha
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Satish Girimaji
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Preeti Jacob
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Deepak Jayarajan
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Keshav Kumar
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Gitanjali Narayanan
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Madhu Khullar
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Niranjan Khandelwal
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Abhishek Ghosh
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Nainesh Joshi
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Ningthoujam Debala Chanu
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Fujica M.C.
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Victoria Ph.
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Celina Phurailatpam
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Debangana Bhattacharya
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Bidisha Haque
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Alisha Nagraj
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Arpita Ghosh
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Anirban Basu
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Mriganka Pandit
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Subhadip Das
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Pawan Maurya
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Amritha Gourisankar
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Geetha Rani T
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Sujatha B
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Madhavi Rangaswamy
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Caroline Fall
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Kiran KN
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Ramya MC
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Chaitra Urs
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Santhosh N
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Somashekhara R
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Divyashree K
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Arathi Rao
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Poornima R
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Saswathika Tripathy
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Neha Parashar
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Nayana K B
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Ashwini Seshadri
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Sathish Kumar
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Suneela Baligar
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Thamodaran Arumugam
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Apoorva Safai
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Anthony Cyril
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Ashika Roy
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Dhanalakshmi D
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Shivamma D
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
  • Bhavana B R
    for the Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)

Description

<jats:sec id="ab-zoi230394-4"><jats:title>Importance</jats:title><jats:p>Arsenic, a contaminant of groundwater and irrigated crops, is a global public health hazard. Exposure to low levels of arsenic through food extends well beyond the areas with high arsenic content in water.</jats:p></jats:sec><jats:sec id="ab-zoi230394-5"><jats:title>Objective</jats:title><jats:p>To identify cognitive impairments following commonly prevalent low-level arsenic exposure and characterize their underlying brain mechanisms.</jats:p></jats:sec><jats:sec id="ab-zoi230394-6"><jats:title>Design, Setting, and Participants</jats:title><jats:p>This multicenter population-based cohort study analyzed cross-sectional data of the Indian Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA) cohort, recruited between November 4, 2016, and May 4, 2019. Participants aged 6 to 23 years were characterized using deep phenotyping measures of behavior, neuropsychology, psychopathology, brain neuroimaging, and exposure to developmental adversities and environmental neurotoxins. All analyses were performed between June 1, 2020, and December 31, 2021.</jats:p></jats:sec><jats:sec id="ab-zoi230394-7"><jats:title>Exposure</jats:title><jats:p>Arsenic levels were measured in urine as an index of exposure.</jats:p></jats:sec><jats:sec id="ab-zoi230394-8"><jats:title>Main Outcomes and Measures</jats:title><jats:p>Executive function measured using the cVEDA neuropsychological battery, gray matter volume (GMV) from T1-weighted magnetic resonance imaging, and functional network connectivity measures from resting state functional magnetic resonance imaging.</jats:p></jats:sec><jats:sec id="ab-zoi230394-9"><jats:title>Results</jats:title><jats:p>A total of 1014 participants aged 6 to 23 years (589 male [58.1%]; mean [SD] age, 14.86 [4.79] years) were included from 5 geographic locations. Sparse-partial least squares analysis was used to describe a negative association of arsenic exposure with executive function (<jats:italic>r</jats:italic> = −0.12 [<jats:italic>P</jats:italic> = 5.4 × 10<jats:sup>−4</jats:sup>]), brain structure (<jats:italic>r</jats:italic> = −0.20 [<jats:italic>P</jats:italic> = 1.8 × 10<jats:sup>−8</jats:sup>]), and functional connectivity (within network, <jats:italic>r</jats:italic> = −0.12 [<jats:italic>P</jats:italic> = 7.5 × 10<jats:sup>−4</jats:sup>]; between network, <jats:italic>r</jats:italic> = −0.23 [<jats:italic>P</jats:italic> = 1.8 × 10<jats:sup>−10</jats:sup>]). Alterations in executive function were partially mediated by GMV (<jats:italic>b</jats:italic> = −0.004 [95% CI, −0.007 to −0.002]) and within-network functional connectivity (<jats:italic>b</jats:italic> = −0.004 [95% CI, −0.008 to −0.002]). Socioeconomic status and body mass index moderated the association between arsenic and GMV, such that the association was strongest in participants with lower socioeconomic status and body mass index.</jats:p></jats:sec><jats:sec id="ab-zoi230394-10"><jats:title>Conclusions and Relevance</jats:title><jats:p>The findings of this cross-sectional study suggest that low-level arsenic exposure was associated with alterations in executive functioning and underlying brain correlates. These results indicate potential detrimental consequences of arsenic exposure that are below the currently recommended guidelines and may extend beyond endemic risk areas. Precision medicine approaches to study global mental health vulnerabilities highlight widespread but potentially modifiable risk factors and a mechanistic understanding of the impact of low-level arsenic exposure on brain development.</jats:p></jats:sec>

Journal

  • JAMA Network Open

    JAMA Network Open 6 (5), e2312810-, 2023-05-12

    American Medical Association (AMA)

Citations (1)*help

See more

Report a problem

Back to top